West Pharmaceutical Services, Inc. (WST) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $267.93. It has a SharesGrow Score of 66/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of WST = $166.35 (-37.9% from the current price, the stock appears overvalued). Analyst consensus target is WST = $303 (+13.2% upside).
Valuation: WST trades at a trailing Price-to-Earnings (P/E) of 38.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.59.
Financials: revenue is $3.1B, +2.2%/yr average growth. Net income is $494M, growing at -5.2%/yr. Net profit margin is 16.1% (healthy). Gross margin is 35.9% (-3.5 pp trend).
Balance sheet: total debt is $417M against $3.2B equity (Debt-to-Equity (D/E) ratio 0.13, conservative). Current ratio is 3.02 (strong liquidity). Debt-to-assets is 9.8%. Total assets: $4.3B.
Analyst outlook: 10 / 14 analysts rate WST as buy (71%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 29/100 (Fail), Growth 30/100 (Fail), Past 100/100 (Pass), Health 100/100 (Pass), Moat 57/100 (Partial), Future 73/100 (Pass), Income 70/100 (Pass).
